Base
First Name | Veronica |
Last Name | Ajewole |
City | Katy |
State/Province | TX |
Country | |
Organization, Practice Name, University, or Government Agency | Houston Methodist Hospital |
Title | Clinical Pharmacist Specialist |
Credentials | |
Work Phone | 8327585732 |
Cell Phone | 8327585732 |
Best way to reach you | |
Certifications | |
Years of Experience in Oncology Practice (clinically or operational) | |
How did you hear about us? | |
Bio | Dr. Veronica B Ajewole earned her BS in Biochemistry from University of Ado Ekiti in Nigeria after which she worked as a Quality Control Personnel in an ISO-Certified Large-Scale Drug Manufacturing company for a few years before relocating to the United States in 2009. She completed her Doctor of Pharmacy degree with a Summa Cum Laude from Texas Southern University in 2015. After this, she completed her Post-Graduate Year 1 Pharmacy Residency and Year 2 Oncology pharmacy residency training at Houston Methodist Hospital in 2016 and 2017 after which she assumed the role of an Assistant Professor of Pharmacy Practice at Texas Southern University. Currently, she is a Board-Certified Oncology Pharmacist with Clinical Pharmacy practice privilege at Houston Methodist Hospital Cancer Center, Texas Medical Center location. Dr. Ajewole’s didactic teaching expertise is in diverse oncology-related topics for professional students in the College of Pharmacy and Health Science as well as development/implementation of a pharmacy practice driven integrated lab experience for 2nd year professional PharmD students. She is a seasoned clinical preceptor and mentor for several students and residents. Dr. Ajewole developed oral chemotherapy medication therapy management clinical service at her practice site: Houston Methodist Hospital. She recently received a grant to support implementation of medication therapy management of oral chemotherapy to improve outcome of cancer patients. She is also leading a funded grant to reformulate capecitabine to enhance the PK/PD parameters which will lead to improved patient compliance, medication adherence, and decreased side effects. Dr. Ajewole and her team also received a Susan G Komen community grant to establish Breast Cancer Screening and Prevention Center at TSU. She is an author of publications in peer-reviewed journals and a reviewer for peer-reviewed articles. She has had several poster and platform presentations in local and national conferences. |
Subscribe to Oncolytics Today |